Article
Marine n-3 fatty acids promote size reduction of visceral adipose depots, without altering body weight and composition, in male Wistar rats fed a high-fat diet.
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Blindern, Norway.
The British journal of nutrition (impact factor:
3.45).
05/2009;
102(7):995-1006.
DOI:10.1017/S0007114509353210
pp.995-1006
Source: PubMed
-
Citations (0)
- Cited In (4)
-
Article: High-glycemic index carbohydrates abrogate the antiobesity effect of fish oil in mice.
[show abstract] [hide abstract]
ABSTRACT: Fish oil rich in n-3 polyunsaturated fatty acids is known to attenuate diet-induced obesity and adipose tissue inflammation in rodents. Here we aimed to investigate whether different carbohydrate sources modulated the antiobesity effects of fish oil. By feeding C57BL/6J mice isocaloric high-fat diets enriched with fish oil for 6 wk, we show that increasing amounts of sucrose in the diets dose-dependently increased energy efficiency and white adipose tissue (WAT) mass. Mice receiving fructose had about 50% less WAT mass than mice fed a high fish oil diet supplemented with either glucose or sucrose, indicating that the glucose moiety of sucrose was responsible for the obesity-promoting effect of sucrose. To investigate whether the obesogenic effect of sucrose and glucose was related to stimulation of insulin secretion, we combined fish oil with high and low glycemic index (GI) starches. Mice receiving the fish oil diet containing the low-GI starch had significantly less WAT than mice fed high-GI starch. Moreover, inhibition of insulin secretion by administration of nifedipine significantly reduced WAT mass in mice fed a high-fish oil diet in combination with sucrose. Our data show that the macronutrient composition of the diet modulates the effects of fish oil. Fish oil combined with sucrose, glucose, or high-GI starch promotes obesity, and the reported anti-inflammatory actions of fish oil are abrogated. In conclusion, our data indicate that glycemic control of insulin secretion modulates metabolic effects of fish oil by demonstrating that high-GI carbohydrates attenuate the antiobesity effects of fish oil.AJP Endocrinology and Metabolism 02/2012; 302(9):E1097-112. · 4.75 Impact Factor -
Dataset: Of mice and men: Factors abrogating the antiobesity effect of omega-3 fatty acids
-
Article: Of mice and men Factors abrogating the antiobesity effect of omega-3 fatty acids
[show abstract] [hide abstract]
ABSTRACT: T he ability of n-3 long chain poly-unsaturated fatty acids (PUFAs) to prevent high fat diet-induced obesity in rodents is well documented. Evidence for a similar effect in humans is, however, limited. Intervention studies in humans are inconclusive and epidemiological studies are dichotomous. Our recent finding that sucrose and other high glycemic index carbohydrates abrogate the antiobesity effect of n-3 PUFAs might, at least in part, provide an explanation to the apparent discrepancy between human and rodent intervention studies, and the lack of effect in some human trials. In addition to the amount and type of carbohydrates, the levels of n-6 PUFAs, linoleic acid in particular, in the background diet might influence the antiobesogenic effect of n-3 PUFAs. Lastly, it is plausible that the quantity of persistent organic pollutants in fish oil, and seafood rich in n-3 PUFAs, might have an influence on the outcome of the trials. A large number of studies have documented the ability of fish oil to attenuate, 1-9 and in at least one case, totally prevent 10 high fat diet-induced obesity in rodents. Moreover, at least one study has demonstrated that n-3 PUFAs are able to reduce the amount of body fat in mice already made obese by a high fat diet. 11 In view of the promising rodent studies one would expect fish oil and seafood enriched in n-3 PUFAs to be a useful, effective and safe tool to reduce obesity also in humans. Epidemiological associations between intake of n-3 PUFAs and obesity develop-ment are, however, inconclusive. WhereasAdipocyte. 08/2012; 1(3):173-176.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
% lard
32 % reductions
adipose depots
adipose tissue distribution
body composition
Carcass analyses
Cpt2 mRNA expression
epididymal depots
Feed consumption
gene expression
Magnetic resonance imaging
marine n-3 fatty acids
mesenteric adipose depots
mRNA expression
n-3 FA group
n-3 FA-fed rats
plasma lipid concentrations
smaller visceral
visceral adipose depots
visceral compartment